203 related articles for article (PubMed ID: 35183115)
1. Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.
Ke D; Yu Y; Li C; Han J; Xu J
Mol Med; 2022 Feb; 28(1):22. PubMed ID: 35183115
[TBL] [Abstract][Full Text] [Related]
2. Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway.
Ke D; Xu H; Han J; Dai H; Wang X; Luo J; Yu Y; Xu J
Biomed J; 2024 Feb; 47(1):100605. PubMed ID: 37179010
[TBL] [Abstract][Full Text] [Related]
3. JNK1 regulates RANKL-induced osteoclastogenesis
Ke D; Ji L; Wang Y; Fu X; Chen J; Wang F; Zhao D; Xue Y; Lan X; Hou J
FASEB J; 2019 Oct; 33(10):11082-11095. PubMed ID: 31295022
[TBL] [Abstract][Full Text] [Related]
4. 1α,25-(OH)
Yu C; Zhu Y; Lv X; Wang Y
In Vitro Cell Dev Biol Anim; 2021 Oct; 57(9):878-885. PubMed ID: 34780049
[TBL] [Abstract][Full Text] [Related]
5. IL-17A inhibits the degradation of RANKL in osteoblasts by inhibiting BCL2-Beclin1-autophagy signaling.
Chen XX; Wu HJ; Ke DS; Zhu YR
In Vitro Cell Dev Biol Anim; 2023 Apr; 59(4):300-311. PubMed ID: 37002492
[TBL] [Abstract][Full Text] [Related]
6. Rubiadin-1-methyl ether inhibits BECN1 transcription and Beclin1-dependent autophagy during osteoclastogenesis by inhibiting NF-κB p65 activation.
Cai S; Chen Y; Chen J; Wei W; Pan J; Wu H
Exp Biol Med (Maywood); 2023 Sep; 248(17):1518-1526. PubMed ID: 37750211
[TBL] [Abstract][Full Text] [Related]
7. Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses.
Zhang G; Wang Y; Tang G; Ma Y
BMC Complement Altern Med; 2019 Oct; 19(1):269. PubMed ID: 31615565
[TBL] [Abstract][Full Text] [Related]
8. Oestrogen-activated autophagy has a negative effect on the anti-osteoclastogenic function of oestrogen.
Cheng L; Zhu Y; Ke D; Xie D
Cell Prolif; 2020 Apr; 53(4):e12789. PubMed ID: 32157750
[TBL] [Abstract][Full Text] [Related]
9. Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis.
Ke D; Zhu Y; Zheng W; Fu X; Chen J; Han J
Biochimie; 2019 Dec; 167():217-227. PubMed ID: 31654668
[TBL] [Abstract][Full Text] [Related]
10. IL-17A modulates osteoclast precursors' apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis.
Xue Y; Liang Z; Fu X; Wang T; Xie Q; Ke D
Biochem Biophys Res Commun; 2019 Jan; 508(4):1088-1092. PubMed ID: 30553450
[TBL] [Abstract][Full Text] [Related]
11. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression.
Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z
PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo.
Zhong J; Wang Z; Yuan W; Shen Y; Chen L
Int Immunopharmacol; 2022 Jun; 107():108631. PubMed ID: 35219162
[TBL] [Abstract][Full Text] [Related]
13. IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK/mTOR/Beclin1 pathway.
Tang H; Zhu S; Chen K; Yuan S; Hu J; Wang H
PLoS One; 2023; 18(2):e0281845. PubMed ID: 36795736
[TBL] [Abstract][Full Text] [Related]
14. IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro.
Ke D; Fu X; Xue Y; Wu H; Zhang Y; Chen X; Hou J
Biochem Biophys Res Commun; 2018 Mar; 497(3):890-896. PubMed ID: 29476739
[TBL] [Abstract][Full Text] [Related]
15. Autophagy exerts pivotal roles in regulatory effects of 1α,25-(OH)
Ji L; Gao J; Kong R; Gao Y; Ji X; Zhao D
Biochem Biophys Res Commun; 2019 Apr; 511(4):869-874. PubMed ID: 30850163
[TBL] [Abstract][Full Text] [Related]
16. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
17. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Boyce BF; Xing L
J Bone Miner Res; 2004 Feb; 19(2):207-13. PubMed ID: 14969390
[TBL] [Abstract][Full Text] [Related]
18. Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation.
Otero JE; Dai S; Foglia D; Alhawagri M; Vacher J; Pasparakis M; Abu-Amer Y
J Biol Chem; 2008 Sep; 283(36):24546-53. PubMed ID: 18567579
[TBL] [Abstract][Full Text] [Related]
19. TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss.
Yang C; Tao H; Zhang H; Xia Y; Bai J; Ge G; Li W; Zhang W; Xiao L; Xu Y; Wang Z; Gu Y; Yang H; Liu Y; Geng D
Autophagy; 2022 Dec; 18(12):2817-2829. PubMed ID: 35255774
[TBL] [Abstract][Full Text] [Related]
20. RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in alymphoplasia mice by promoting NF-κB2 processing by IKKα.
Taniguchi R; Fukushima H; Osawa K; Maruyama T; Yasuda H; Weih F; Doi T; Maki K; Jimi E
J Biol Chem; 2014 Mar; 289(11):7349-61. PubMed ID: 24488495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
